99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions
| Autor: | Subha Saeed, Ahmed Ibrahim Ahmed, Payam Pournazari, Jean Michel Saad, Mouaz H. Al-Mallah, Yushui Han |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
medicine.diagnostic_test business.industry Amyloidosis Restrictive cardiomyopathy chemistry.chemical_element medicine.disease Scintigraphy Technetium chemistry Cardiac amyloidosis Magnetic imaging Heart failure medicine Cardiac scintigraphy Radiology Cardiology and Cardiovascular Medicine business |
| Zdroj: | Heart Failure Reviews. 27:1493-1503 |
| ISSN: | 1573-7322 1382-4147 |
| Popis: | Cardiac amyloidosis (CA) is an underdiagnosed form of restrictive cardiomyopathy leading to a rapid progression into heart failure. Evaluation of CA requires a multimodality approach making use of echocardiography, cardiac magnetic imaging, and nuclear imaging. Technetium (Tc)-labeled cardiac scintigraphy has witnessed a resurgence in its application for the workup of CA. Advancements in disease-modifying therapies have fueled the rapid adoption of cardiac scintigraphy using bone tracers and the need for transformative novel studies. The goal of this review is to present diagnostic utility, currently recommended protocols, as well as a glimpse into the rapid evolution of Tc-labeled cardiac scintigraphy in the diagnosis of CA. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink